Header Logo

Connection

LAWRENCE E GINSBERG to Administration, Oral

Back to Details
This is a "connection" page, showing publications LAWRENCE E GINSBERG has written about Administration, Oral.
LAWRENCE E GINSBERG
Connection Strength
0.032
Administration, Oral
  1. Phase II trial of everolimus and erlotinib in patients with platinum-resistant recurrent and/or metastatic head and neck squamous cell carcinoma. Ann Oncol. 2015 Jul; 26(7):1476-80.
    View in: PubMed
    Score: 0.023
  2. Phase II study of the antiangiogenesis agent thalidomide in recurrent or metastatic squamous cell carcinoma of the head and neck. Cancer. 2001 Nov 01; 92(9):2364-73.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.